Crossmark

Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

Crossref DOI link: https://doi.org/10.1016/j.rpsmen.2018.03.003

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

González-Blanco, Leticia

García-Portilla, María P.

García-Álvarez, Leticia

de la Fuente-Tomás, Lorena

Iglesias García, Celso

Sáiz, Pilar A.

Rodríguez-González, Susana

Coto-Montes, Ana

Bobes, Julio
Funding

Funding for this research was provided by:

Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (PI13/02263)

European Regional Development Fund
License Information

Text and Data Mining valid from 2019-01-01
More Information

This article is maintained by: Elsevier

Article Title: Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

Journal Title: Revista de Psiquiatría y Salud Mental (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsmen.2018.03.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rpsm.2018.03.004

Content Type: article

Copyright: © 2018 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.